Doctors often advise a dosage of 6001200 mg twice a week
Please check your cart before checkout to see availability and pricing
Despite its promising applications, AOD-9604 remains unapproved by the FDA for weight loss or clinical use
Results on a supervised 503A injectable protocol develop faster and more consistently than topical application alone
Wound Healing Skin, Burns, Diabetic Ulcers & Angiomodulation (PMC, 2021) A comprehensive wound healing review published in Frontiers in Pharmacology confirmed BPC-157s applicability across incisional, excisional, deep burn, diabetic ulcer, alkali burn, and fistula wound models with equivalent efficacy regardless of route of application (systemic or local)
Serious reactions are exceptionally uncommon but can include allergic responses in sensitive individuals